Dyax

Contact
dyax.com
+1617-225-2500

Dyax Corp.

300 Technology Square
02139 Cambridge
USA
+1617-225-2500
dyax.com
Contact
Profile Products News
Contact

About Dyax

Dyax is focused on advancing novel biotherapeutics for unmet medical needs, with an emphasis on oncology and inflammatory indications. Dyax utilizes its proprietary drug discovery technology to identify antibody, small protein and peptide compounds for clinical development.

Dyax is headquartered in Cambridge, Massachusetts, and has antibody discovery facilities in Liege, Belgium.

Read more about Dyax
Facts about Dyax
  • Industry : Pharma

Product portfolio of Dyax

Product portfolio

Show all

News about Dyax

Dyax

15-May-2015 | people

Dyax Corp. Appoints Dr. Abbie Celniker to Board of Directors

Dyax Corp.  announced the appointment of Abbie Celniker, Ph.D., to its Board of Directors.Dr. Celniker currently serves as the President and Chief ...

Read news
Dyax

20-Nov-2014 | career

Dyax Corp. Recognized as a "Top Place to Work" by The Boston Globe

Dyax Corp. announced that it has been named one of the Top Places to Work in Massachusetts by The Boston Globe."Great people build great businesses. At ...

Read news
Dyax

18-Oct-2012 | people

Dyax Corp. Appoints Marc Kozin to Board of Directors

Dyax Corp., a developer of novel biotherapeutics, announced the appointment of Marc Kozin to its Board of Directors. "Marc brings to our Board nearly 30 ...

Read news
Dyax

24-Sep-2012 | business & finance

Dyax Corp. and Kadmon sign strategic licensing agreement for antibody inhibitor DX-2400

Novel MMP-14 Inhibitor to be Developed in Multi-Indication Oncology Program

Read news
Dyax

22-Aug-2012 | people

Dyax Corp. Creates COO Position and Expands Executive Roles

Ivana Magovcevic-Liebisch, Ph.D., J.D., Named Chief Operating Officer

Read news
Dyax

05-Mar-2012 | people

Dyax Announces Appointment of Dr. Burt Adelman as Chief Medical Officer

Dyax Corp. announced the appointment of Burt Adelman, M.D. as Chief Medical Officer. Dr. Adelman will lead the development and regulatory strategy for the ...

Read news
Dyax

07-Nov-2011 | people

Dyax Corp. Appoints Ron Cohen, M.D. and Paolo Pucci to Board of Directors

Dyax Corp. announced the appointment of Ron Cohen, M.D. and Paolo Pucci to its Board of Directors. In addition to their appointment as Directors, Dr. Cohen ...

Read news
Dyax

08-Aug-2011 | research and development

Dyax Announces Treatment of First Patient in Phase 2 Trial of Ecallantide for ACE Inhibitor-Induced Angioedema

Dyax Corp. announced treatment of the first patient in a Phase 2 trial evaluating the efficacy and safety of ecallantide, a potent, selective, reversible ...

Read news
Show more news about Dyax

Here you will find Dyax Corp.